[ad_1] Preliminary results from a Phase I clinical trial demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion in individuals …
Read More »An HIV immunotherapy study with proof of concept passes the Phase 1 safety trial
[ad_1] HIV infecting a human cell. Credit: NIH Preliminary results from a Phase I clinical trial demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T …
Read More »The first anti-HIV immunotherapy drug proves safe in the Phase 1 trial
[ad_1] Scientists hoping to cure HIV have proven that an immunotherapy drug can be safely used in humans. The Phase 1 trial is an important but early step for the University of …
Read More »Natural killer cells often overlooked can be the key to cancer immunotherapy
[ad_1] Dr. Michele Ardolino (pictured here) and Dr. David Raulet and their colleagues have discovered that natural killer cells could play an important role in the body's response to cancer immunotherapy drugs …
Read More »Immunotherapy could work by releasing the body's natural killer cells
[ad_1] Scientists have brought new insights into the workings of immunotherapy, a breakthrough cancer treatment that harnesses the power of the immune system. By focusing on the role of white blood cells …
Read More »Cancer: The Edition of the CRISPR Gene Could Make Immunotherapy Less Expensive
[ad_1] CRISPR is obviously a fascinating technology. Its main feature is that it can literally be used to cut, dice and manipulate the functions of the body's genetic code that could have …
Read More »Immunotherapy and the slow evolution towards less toxic tools to fight cancer – Technology News, Firstpost
[ad_1] John Ryan is just one of the miracles to emerge from the Johns Hopkins Cancer Unit in Baltimore. An immunotherapy treatment – very effective in a minority of patients – saved …
Read More »